ArticlebioRxiv : the preprint server for biology2025
Calibrated Variant Effect Prediction at the Residue Level Using Conditional Score Distributions.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Effective clinical use of variant effect prediction (VEP) requires models that are both accurate and well-calibrated. Calibration refers to a model's ability to produce meaningful and reliable probability estimates. Here, we propose a practical path toward robust VEP calibration by calibrating at the residue-level rather than using global or per-protein schemes. We identify variant subgroups that benefit from targeted calibration and show that, while VEPs appear well calibrated on average, they remain markedly miscalibrated within these subgroups. Leveraging these insights, we develop RaCoon (Residue-aware Calibration via Conditional distributions), implemented on ESM1b, which provides multicalibrated and interpretable predictions across diverse variant subgroups and significantly improves performance across multiple benchmarks. Targeted residue-level calibration not only improves overall calibration but, for most models, also yields gains in global AUROC. Specifically, RaCoon increases AUCROC from 0.912 to 0.924. Our calibration strategy, guided by model-specific feature distributions, is readily transferable to other VEPs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.